Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

Archive ouverte

Arotcarena, Marie-Laure | Dovero, Sandra | Prigent, Alice | Bourdenx, Mathieu | Camus, Sandrine, M. J. | Porras, Gregory | Thiolat, Marie-Laure | Tasselli, Maddalena | Aubert, Philippe | Kruse, Niels | Mollenhauer, Brit | Damas, Ines Trigo | Estrada, Cristina | Garcia-Carrillo, Nuria | Vaikath, Nishant | El-Agnaf, Omar | Herrero, Maria Trinidad | Vila, Miquel | Obeso, José | Derkinderen, Pascal | Dehay, Benjamin | Bezard, Erwan

Edité par CCSD ; Oxford University Press -

International audience. In Parkinson's disease, synucleinopathy is hypothesized to spread from the enteric nervous system, via the vagus nerve, to the CNS. Here, we compare, in baboon monkeys, the pathological consequences of either intrastriatal or enteric injection of α-synuclein-containing Lewy body extracts from patients with Parkinson's disease. This study shows that patient-derived α-synuclein aggregates are able to induce nigrostriatal lesions and enteric nervous system pathology after either enteric or striatal injection in a non-human primate model. This finding suggests that the progression of α-synuclein pathology might be either caudo-rostral or rostro-caudal, varying between patients and disease subtypes. In addition, we report that α-synuclein pathological lesions were not found in the vagal nerve in our experimental setting. This study does not support the hypothesis of a transmission of α-synuclein pathology through the vagus nerve and the dorsal motor nucleus of the vagus. Instead, our results suggest a possible systemic mechanism in which the general circulation would act as a route for long-distance bidirectional transmission of endogenous α-synuclein between the enteric and the central nervous systems. Taken together, our study provides invaluable primate data exploring the role of the gut-brain axis in the initiation and propagation of Parkinson's disease pathology and should open the door to the development and testing of new therapeutic approaches aimed at interfering with the development of sporadic Parkinson's disease.

Consulter en ligne

Suggestions

Du même auteur

Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain

Archive ouverte | Teil, Margaux | CCSD

International audience. Abstract Aggregation of α-synuclein (α-syn) is the cornerstone of neurodegenerative diseases termed synucleinopathies, which include Parkinson’s Disease (PD), Dementia with Lewy Bodies (DLB),...

Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology

Archive ouverte | Teil, Margaux | CCSD

International audience. Abstract Synucleinopathies encompass several neurodegenerative diseases, which include Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. These diseases are character...

Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies

Archive ouverte | Arotcarena, Marie-Laure | CCSD

International audience. The synucleinopathies Parkinson's disease (PD) and Multiple system atrophy (MSA) - characterized by α-synuclein intracytoplasmic inclusions into, respectively, neurons and oligodendrocytes - ...

Chargement des enrichissements...